Insulin costs: Novo Nordisk to lower list price for insulin products, following similar move by Eli Lilly

Novo Nordisk will lower the U.S. list price of some of its insulin products by up to 75%, the Danish drugmaker said Tuesday. The change — which will take effect on Jan. 1, 2024 — follows a similar move by Eli Lilly, which said this month that it will lower the list price for several of its…#novonordisk #danish #elililly #humalog #followingelilillys #larrylevitt #kff #staciedusetzina #nashville #tennessee
Source: Reuters: Health - Category: Consumer Health News Source Type: news